Abstract
Tetracyclines are frequently used in food-producing animals to treat, control, and prevent microbial diseases. Concerns are raised regarding the effects of residual levels of tetracycline, which may be present in the food supply, for emergence of drug-resistance and transfer of antibiotic-resistance gene in intestinal microbiota. In contrast, no information is available regarding the possible effects of residual tetracycline on the gastrointestinal epithelial layer barrier-disruption. This study investigates the outcome of tetracycline treatment on intestinal epithelial cells integrity. Intestinal epithelial cells (T84) were treated at concentrations of 0.015, 0.15, 1.5, 15 and 150 μg/ml for 48 h in an in vitro cell culture model. The permeability study revealed that 15 and 150 μg/ml of tetracycline causes barrier disruption. Whereas the altered mRNA expression of notch-3, notch-4, claudin-2, claudin-8, claudin-10, claudin-15, gap junction alpha 8 and delta 2 and integrin, alpha 3 and alpha L, which are cell-integrity-related genes starts at 1.5 μg/ml tetracycline after 48 h treatment. Translocation of GFP-labeled bacteria from apical to basal comportment provides proof of concept to intestinal barrier disruption. This study is the first to evaluate whether residual concentrations of tetracycline impact epithelial cell integrity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
